New research has found that an existing ADHD medication greatly reduced the number of days people with a methamphetamine dependence used the drug. With no current drug treatment to assist people in getting off meth, the study’s findings are promising.
Paul McClure is a writer at Collider and New Atlas. He focuses on themes related to medicine and healthcare, alternative medicine, and health and wellness, often exploring topics such as data, nutrition, and the impact of AI on diagnostics and drug development. His work has been featured in notable publications, including Collider and New Atlas.